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Abstract
Increasing evidence shows that cognitive impairment 
and brain abnormalities can appear early in the first 
episodes of schizophrenia, but it is currently debated how 
brain changes can correlate with clinical presentation of 
schizophrenic patients. Of note, this report describes the 
case of a young schizophrenic male presenting parietal 
magnetic resonance/positron emission tomography 
abnormalities and cognitive impairment, documented 
by specific neuropsychological tests. In our knowledge 
only few studies have investigated if neuropsychological 
abnormalities could be concomitant with both structural 
and functional neuroimaging. This case shows that 
impairment in specific cognitive domains is associated 
with structural/functional brain abnormalities in the 
corresponding brain areas (frontal and parietal lobes), 
supporting the hypothesis of disconnectivity, involving a 
failure to integrate anatomical and functional pathways. 
Future research would define the role of cognitive impair-
ment and neurodegeneration in psychiatric nosography 
and, in particular, their role in the early phases of illness 
and long-term outcome of schizophrenic patients. 
Key words: Positron emission tomography; Magnetic 
resonance; Schizophrenia; Neuropsychology
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Core tip: Schizophrenia is associated with impairment 
in executive function, verbal memory, verbal fluency 
and attention. Neuropsychological tests are associated 
with structural and functional brain alterations. This 
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case report is an example of the potential correlation 
between clinical symptoms (e.g. , cognitive impairment) 
and brain changes. These data may help in the prediction 
of possible outcome of schizophrenia patients.
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INTRODUCTION
A number of data would indicate schizophrenia as a 
progressive neurodegenerative disorder[1] whose outcome 
is influenced by many biological and clinical factors[2]. 
Of note, recent literature shows that neuropsychological 
deficits at onset may predict the clinical course of illness[3] 
being often associated with frontal and parietal lobe 
dysfunctions[4-6]. Moreover, a recent trial found that brain 
abnormalities of schizophrenic patients change according 
to age at onset. In particular, early onset patients show 
parietal abnormalities, while adult onset patients exhibit 
frontal and temporal ones[7].
To our knowledge there are few studies[8-10] associating 
cognitive frontal and parietal deficits with structural 
[magnetic resonance (MR)] and functional neuroimaging 
[positron emission tomography (PET)] and the anato-
mical and functional relationships underlying this deficit 
remain to be elucidated. Dysconnectivity, a failure in 
functional integration, is considered a key mechanism 
in the pathophysiology of cognitive impairments (in 
particular working memory performance) in individuals 
with schizophrenia[11].
The present paper deals with a recent diagnosed 
schizophrenic patient showing frontal and parietal lobe 
MR/PET abnormalities clinically associated with deficits 
in the corresponding cognitive domains. 
CASE REPORT
The patient was a 19-year-old man admitted in our 
department. The patient showed nor psychiatric comor-
bidity with an Axis Ⅰ disorder neither personality disorders. 
A neurological exam, performed by a neurologist, was 
negative. Diagnosis of undifferentiated schizophrenia 
and exclusion of comorbid conditions were assessed 
through the administration of semi-structured interviews 
based on DSM-Ⅳ criteria (SCID Ⅰ and Ⅱ). Patient had 
family history for psychiatric disorders: The father was an 
alcohol abuser, one schizophrenic uncle (father’s brother) 
committed suicide and the grandmother in mother line 
was affected by bipolar disorder. At the admission in our 
ward the patient was drug-naïve and showed persecutory 
delusion, auditory hallucinations, thought/behavioural 
disorganization and a duration of untreated psychosis 
of 9 mo[12]. Baseline score at Positive and Negative 
Syndrome Scale[13] was 84, while baseline score at Brief 
Psychiatric Rating Scale was 55[14]. In the first days of 
admission patient underwent to neuropsychological tests, 
cerebral MR and cerebral PET.
A neuropsychological battery was designed to encompass 
the areas believed to be affected by Schizophrenia[15]. 
Results and standard scores are summarized in Table 1. 
Patient’s neurocognitive performances provided evidence 
for impairment in the following domains: Executive function 
(Cognitive Estimation, Verbal fluency, Trail Making Test), 
verbal memory, verbal ability (Boston Naming Test, 
phonemic Verbal Fluency) and attention (Visual Search, 
Trail Making Test). In addition, the patient failed in two 
Wechsler Adult Intelligence Scale[16] subscales: Verbal 
Comprehension Index and Perceptual Organization Index. 
MR was performed using a circular polarized head coil 
and included Turbo Spin-Echo T1-weighted sequences, 
T2-weighted sequences and FLAIR. Imaging in three 
planes was performed using 5-mm slice thickness. MR 
revealed normal-sized ventricles, normal-sized subara-
chnoidal spaces, no abnormalities in gray matter, but 
bilaterally soft hyper-intensities in superior parietal lobe[4] 
periventricular white matter.
Fluorodeoxyglucose (FDG) was injected in condition 
of rest and fasting and after 30 min three-dimensional 
scan was performed. The images were compared to a 
cohort of normal ones. Fluoro-D-Glucose PET (Figures 1 
and 2) showed glucose frontal and parietal lobes hypo-
metabolism bilaterally. No further abnormalities in FDG 
distribution were observed. 
MR and PET were performed by neuroradiologists 
collaborating within our department.
Of note, neuropsychological results are consistent 
with outlined MR abnormalities and PET images (fronto-
parietal abnormalities)[17].
DISCUSSION
The present case report confirms data from literature of 
early cognitive deficits in the course of schizophrenia[18,19] 
and neuroimaging parietal abnormalities in early onset 
schizophrenic patients[7,20,21]. In addition, the corre-
spondence between cognitive deficits and morphological/
functional brain alterations[22] contributes to clarify the 
influence of brain changes in schizophrenia clinical 
presentation as well as to support the hypothesis of 
schizophrenia as a neurodegenerative disorder[23,24]. 
Recent trials found that brain abnormalities are more 
severe in patients with a longer duration of illness[25-27], 
novel antipsychotics are promising molecules for their 
efficacy in stopping the neurodegenerative process[28,29]. In 
this context cognitive and neuroimaging follow-up of our 
case can be useful to discriminate if neurodegenerative 
process of schizophrenia progresses in the course of 
illness or it is specific of early stages[24,30,31]. Finally, it 
would be important in the future to define the role of 
neuroimaging abnormalities in influencing outcome. MR 
130 June 22, 2017|Volume 7|Issue 2|WJP|www.wjgnet.com
Test Patient score Normal value Result Z-score
Mini-mental state examination        27.19      24-29.19 Normal      0.45
Executive functions: Tower of London   25 20-36 Normal     -0.75
Frontal assessment battery        15.98 13.5-17.3 Normal     -0.95
Cognitive estimation task        19.97   0-18 Failed      2.43
Bizarreness     6 0-4 Failed 4
Problem solving: Raven’s progressive matrices        29.05   18.6-33.05 Normal      0.89
Assessment of cognitive impairment in memory
Verbal memory and learning 
Digit Span         5.75 3.75-8.75 Normal   -0.4
Verbal Learning       10.50   6.50-21.50 Normal     -0.93
Recall of prose: Immediate and after 10 min         3.50   8.00-27.50 Failed     -2.92
Spatial short-term memory (Corsi test)         4.50 3.50-8.50 Normal     -1.20
Attention and speed information processing 
Trail making test
Part A   33   < 93 s Normal
Part B, dual task 161 < 282 s Normal 
Part B-A 128 < 186 s Borderline score     -1.36
Visual search        34.25      31-51.25 Borderline score
Verbal fluency
Phonemic   23 17-59 Borderline score     -1.43
Categories   32 25-58 Normal     -1.15
Language
Boston naming test   31 43-60 Failed     -4.82
Token test   32 29-36 Normal     -0.29
Wechsler adult intelligence scale-revised General IQ = 75 (verbal IQ = 81; 
performance IQ = 74)
  80-120 Borderline score     -2.50
VCI = 5.5; POI = 6.25
Table 1  Neuropsychological results
The standard scores, reported in the second column, are calculated considering a normal population. Our patient’s scores, adjusted for age, sex and 
education are shown in the first column next to each test. A score is considered pathological when the score is present less than 5% of the normal 
population. Sometimes normal scores are considered pathological due to the clinical condition and the global performance. VCI: Verbal comprehension 








Figure 1  D-glucose (fluorodeoxyglucose) positron emission tomography, transversal sections. Pointer 1 displays the frontal lobe hypo-metabolism; pointer 2 
displays the parietal lobe hypo-metabolism.
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and PET could be useful tools to make diagnosis and to 
predict long-term course of schizophrenic illness.
COMMENTS
Case characteristics
A 19-year-old male patient with severe schizophrenia presentation.
Clinical diagnosis
Patient was hospitalized because of prominent persecutory delusion, auditory 
hallucinations, aggressiveness and thought/behavioural disorganization.
Differential diagnosis
Bipolar disorder, substance use disorder.
Laboratory diagnosis
Routine blood tests were resulted within normal limits.
Imaging diagnosis
At magnetic resonance imaging bilaterally soft hyper-intensities in superior 
parietal lobe periventricular white matter were detected, while positron emission 
tomography showed glucose parietal lobes hypo-metabolism bilaterally.
Pathological diagnosis
Schizophrenia, acute episode. 
Treatment
Ziprasidone 80 mg × 2 and Gabapentin 300 mg × 3.
Related reports
Severe cognitive impairment as showed by neuropsychological tests.
Term explanation
Dysconnectivity means abnormal functional integration among brain regions 
resulting in impaired modulation of neurotransmitters.
Experiences and lessons
It is important to perform imaging evaluation and neuropsychological tests to 
better define long-term outcome of schizophrenia patients.
Peer-review
This case report is novel and well designed.
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Figure 2  Fluoro-D-glucose (fluorodeoxyglucose) positron emission tomography, coronal sections. Pointer 1 displays the frontal lobe hypo-metabolism; Pointer 
2 displays the parietal lobe hypo-metabolism.
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